Introduction {#Sec1}
============

Extubation failure in critically ill patients has associated morbidity, but it cannot be safely predicted or avoided. Preventive NIMV has proved beneficial only in hypercapnic patients. We hypothesized that High-flow oxygen therapy may reduce postextubation respiratory failure due to gas humidification, avoidance of lung collapse by moderate PEEP, and work of breathing reduction by dead-space washing.

Objectives {#Sec2}
==========

Our objective was to reduce postextubation respiratory failure with High-flow in high-risk patients.

Methods {#Sec3}
=======

Randomized multicenter trial in patients who successfully passed a spontaneous breathing trial. Only patients with criteria for high-risk of failure were randomized to receive conventional oxygen or High-flow oxygen (Optiflow®: Fisher Paykel) for 24 hours post-extubation. Primary outcome was respiratory failure within 72 hours postextubation. Secondary outcome were: reintubation, ICU and hospital length of stay, and survival. Statistical analysis included multiple logistic regression models.

Results {#Sec4}
=======

The study was stopped after 18 months due to low recruitment. We enrolled 155 patients: 77 with conventional and 78 with High-flow oxygen. Groups were very similar at enrollment. All patients tolerated the High-flow system. We found the projected reduction in postextubation respiratory failure (20.5% vs. 27.3%, p = 0.3) that failed to reach statistical significance due to sample size. Similarly, the benefit in reintubation (16.7% vs. 19.5%, p = 0.6) didn´t reach significance. We found no differences in ICU length of stay, hospital length of stay, and survival. By a logistic regression model, we were able to independently associate high-flow with reduction in postextubation respiratory failure (OR 0.4 p = 0.049), by including COPD, cancer, length of MV, obesity, and cardiac failure in the model.

Conclusions {#Sec5}
===========

High-flow oxygen therapy for 24-h may reduce postextubation respiratory failure in high-risk critically ill patients.
